Panbela Therapeutics, Inc.
PBLA · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,179 | -$7,140 | -$7,120 | -$6,474 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $103 | $124 |
| Change in WC | -$4,472 | $6,881 | -$2,409 | $3,204 |
| Other Non-Cash | $9,531 | -$722 | $34 | $66 |
| Operating Cash Flow | -$2,120 | -$981 | -$9,392 | -$3,080 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | -$400 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$7,569 |
| Investing Cash Flow | $0 | $0 | $0 | -$7,969 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,200 | $0 | -$1,000 | $0 |
| Stock Issued | $0 | $0 | $8,082 | $4,749 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $4,758 |
| Financing Cash Flow | $2,200 | $0 | $7,082 | $4,749 |
| Forex Effect | $3 | $3 | -$6 | $2 |
| Net Chg. in Cash | $83 | -$203 | -$2,316 | $1,671 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59 | $262 | $2,578 | $907 |
| End Cash | $142 | $59 | $262 | $2,578 |
| Free Cash Flow | -$2,120 | -$981 | -$9,392 | -$3,080 |